Di Nuzzo Private Wealth, Inc. Biogen Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $618 Million
- Q4 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 37 shares of BIIB stock, worth $5,229. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37
Previous 44
15.91%
Holding current value
$5,229
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BIIB
# of Institutions
990Shares Held
131MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.36 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.31 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.06 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.04 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$743 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...